Writing

1

Cite Share

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer.

Bustos MA, Yokoe T, Shoji Y, Kobayashi Y, Mizuno S, Murakami T, Zhang X, Sekhar SC, Kim S, Ryu S, Knarr M, Vasilev SA, DiFeo A, Drapkin R, Hoon DSB.

Cell Biosci. 2023 Nov 6;13(1):200. doi: 10.1186/s13578-023-01151-y.

PMID: 37932806 Free PMC article.

2

Cite Share

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, Fabbro M, Ledermann JA, Lorusso D, Vergote I, Ben-Baruch NE, Marth C, Mądry R, Christensen RD, Berek JS, Dørum A, Tinker AV, du Bois A, González-Martín A, Follana P, Benigno B, Rosenberg P, Gilbert L, Rimel BJ, Buscema J, Balser JP, Agarwal S, Matulonis UA; ENGOT-OV16/NOVA Investigators.

N Engl J Med. 2016 Dec 1;375(22):2154-2164. doi: 10.1056/NEJMoa1611310. Epub 2016 Oct 7.

PMID: 27717299 Free article. Clinical Trial.

Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer.

Mahdavi A, Tajalli TR, Dalmar A, Vasilev SA, Lentz SE, Berman ML.

Int J Gynecol Cancer. 2011 Nov;21(8):1436-40. doi: 10.1097/IGC.0b013e31822e7588.

PMID: 21997174

3

Cite Share

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS.

Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.

PMID: 19820372

4

Cite Share

Paying for prevention standardizing the measurement of the value of health care interventions.

Vasilev SA.

Obstet Gynecol Clin North Am. 2002 Dec;29(4):613-43, v. doi: 10.1016/s0889-8545(02)00022-0.

PMID: 12509088 Review.

5

Cite Share

Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers.

Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH.

Gynecol Oncol. 2006 Apr;101(1):120-5. doi: 10.1016/j.ygyno.2005.09.042. Epub 2005 Nov 22.

PMID: 16307792

6

Cite Share

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML.

Gynecol Oncol. 2003 Jul;90(1):181-5. doi: 10.1016/s0090-8258(03)00195-1.

PMID: 12821361

7

Cite Share

Fabric-based exocervical and endocervical biopsy in comparison with punch biopsy and sharp curettage.

Winter M, Cestero RM, Burg A, Felix JC, Han C, Raffo AM, Vasilev S.

J Low Genit Tract Dis. 2012 Apr;16(2):80-7. doi: 10.1097/LGT.0b013e318234262d.

PMID: 22371040 Clinical Trial.

8

Cite Share

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.

Morgan RJ Jr, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.

Cancer Chemother Pharmacol. 2004 Oct;54(4):283-9. doi: 10.1007/s00280-004-0818-x. Epub 2004 Jun 4.

PMID: 15184995 Clinical Trial.

Cite Share

Ectopic pregnancy. Etiology, diagnosis, treatment.

Vasilev SA, Liming PR.

AORN J. 1991 Nov;54(5):1030-1, 1034-9. doi: 10.1016/s0001-2092(07)67035-5.

PMID: 1836125 Review.

3

Cite Share

Prognostic significance of human papillomavirus DNA in vulvar carcinoma.

Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP.

Obstet Gynecol. 1995 May;85(5 Pt 1):709-15. doi: 10.1016/0029-7844(95)00045-s.

PMID: 7724101 Review.

5

Cite Share

Obturator nerve injury: a review of management options.

Vasilev SA.

Gynecol Oncol. 1994 May;53(2):152-5. doi: 10.1006/gyno.1994.1108.

PMID: 8188073 Review.

6

Cite Share

Ovarian cancer metastatic to the brain: what is the optimal management?

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS.

J Surg Oncol. 2001 Nov;78(3):194-200; discussion 200-1. doi: 10.1002/jso.1149.

PMID: 11745806 Review.

7

Cite Share

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP.

J Natl Cancer Inst. 1996 Oct 2;88(19):1361-8. doi: 10.1093/jnci/88.19.1361.

PMID: 8827013 Review.

9

Cite Share

Cervical Cancer Prevention: Toward Cost-Effective Screening.

McMeekin DS, McGonigle KF, Vasilev SA.

Medscape Womens Health. 1997 Dec;2(12):1.

PMID: 9746710

10

Cite Share

Extraperitoneal laparoscopic para-aortic lymph node dissection.

Vasilev SA, McGonigle KF.

Gynecol Oncol. 1996 Jun;61(3):315-20. doi: 10.1006/gyno.1996.0149.

PMID: 8641608

19

Cite Share

Extraperitoneal laparoscopic paraaortic lymph node dissection: development of a technique.

Vasilev SA, McGonigle KF.

J Laparoendosc Surg. 1995 Apr;5(2):85-90. doi: 10.1089/lps.1995.5.85.

PMID: 7612948

20

Cite Share

Basic fibroblast growth factor in retardation of doxorubicin extravasation injury.

Vasilev SA, Morrow C, Morrow CP.

Gynecol Oncol. 1992 Feb;44(2):178-81. doi: 10.1016/0090-8258(92)90035-h.

PMID: 1544596

21

Cite Share

Serum progesterone monitoring in post-molar surveillance.

Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.

Gynecol Oncol. 1994 Sep;54(3):288-91. doi: 10.1006/gyno.1994.1212.

PMID: 7522199

22

Cite Share

Paying for prevention standardizing the measurement of the value of health care interventions.

Vasilev SA.

Obstet Gynecol Clin North Am. 2002 Dec;29(4):613-43, v. doi: 10.1016/s0889-8545(02)00022-0.

PMID: 12509088 Review.

25

Cite Share

Intraoperative pressure profile measurement and continence mechanism adjustment in the Indiana pouch urinary reservoir.

Vasilev SA, Schlaerth JB.

Surg Gynecol Obstet. 1990 Dec;171(6):518-20.

PMID: 2244288

26

Cite Share

Uterine effects of tamoxifen: a prospective study.

McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, Roy S, Wong PT, Simpson JF, Wilczynski SP.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):814-20. doi: 10.1111/j.1525-1438.2006.00525.x.

PMID: 16681767

27

Cite Share

Ability of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopy.

Lonky NM, Mann WJ, Massad LS, Mutch DG, Blanco JS, Vasilev SA, Finan MA, Scotti RJ.

J Reprod Med. 1995 Jul;40(7):530-6.

PMID: 7473444

28

Cite Share

Intestinal peritoneal sling as an adjunct to radical pelvic operation and pelvic irradiation.

Vasilev SA, McGonigle KF, Spencer-Smith EL.

J Am Coll Surg. 1995 May;180(5):568-72.

PMID: 7749532 Clinical Trial.

29

Cite Share

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Mahdavi A, Monk BJ, Ragazzo J, Hunter MI, Lentz SE, Vasilev SA, Tewari KS.

Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.

PMID: 19820372

32

Cite Share

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML.

Gynecol Oncol. 2003 Jul;90(1):181-5. doi: 10.1016/s0090-8258(03)00195-1.

PMID: 12821361

33

Cite Share

Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging.

Kim PY, Monk BJ, Chabra S, Burger RA, Vasilev SA, Manetta A, DiSaia PJ, Berman ML.

Gynecol Oncol. 1998 Jun;69(3):243-7. doi: 10.1006/gyno.1998.5012.

PMID: 9648595

36

Cite Share

Ovarian histopathology in breast cancer patients receiving tamoxifen.

McGonigle KF, Vasilev SA, Odom-Maryon T, Simpson JF.

Gynecol Oncol. 1999 Jun;73(3):402-6. doi: 10.1006/gyno.1999.5378.

PMID: 10366467

37

Cite Share

Scalene lymph node sampling in cervical carcinoma: a reappraisal.

Vasilev SA, Schlaerth JB.

Gynecol Oncol. 1990 Apr;37(1):120-4. doi: 10.1016/0090-8258(90)90319-g.

PMID: 2323607

40

Cite Share

Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract.

Monk BJ, Cook N, Ahn C, Vasilev SA, Berman ML, Wilczynski SP.

Diagn Mol Pathol. 1994 Dec;3(4):283-91. doi: 10.1097/00019606-199412000-00012.

PMID: 7866640

42

Cite Share

Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status.

McGonigle KF, Lantry SA, Odom-Maryon TL, Chai A, Vasilev SA, Simpson JF.

Cancer Lett. 1996 Mar 19;101(1):59-66. doi: 10.1016/0304-3835(96)04114-6.

PMID: 8625283

43

Cite Share

Highly elevated CA125 and tubo-ovarian abscess mimicking ovarian carcinoma.

Macri CI, Vasilev SA.

Gynecol Obstet Invest. 1994;37(2):143-4. doi: 10.1159/000292544.

PMID: 8150372 Free article.

44

Cite Share

Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.

McGonigle KF, Shaw SL, Vasilev SA, Odom-Maryon T, Roy S, Simpson JF.

Am J Obstet Gynecol. 1998 Jun;178(6):1145-50. doi: 10.1016/s0002-9378(98)70315-1.

PMID: 9662294

49

Cite Share

Diagnosis and modern surgical management of ovarian pregnancy.

Vasilev SA, Sauer MV.

Surg Gynecol Obstet. 1990 May;170(5):395-8.

PMID: 2183371

53

Cite Share

Laparoscopically assisted transperineal interstitial brachytherapy with omental flap for locally recurrent endometrial cancer.

Vasilev SA, Vora N, Lee Y.

J Laparoendosc Surg. 1995 Dec;5(6):393-7. doi: 10.1089/lps.1995.5.393.

PMID: 8746992

59

Cite Share

Pelvic abscesses in postmenopausal women.

Vasilev SA, Roy S, Essin DJ.

Surg Gynecol Obstet. 1989 Sep;169(3):243-6.

PMID: 2772795

70

Cite Share

Bilateral giant primary ovarian leiomyomas. A case report.

Macri CI, Vasilev SA.

J Reprod Med. 1993 Jun;38(6):480-2.

PMID: 8331630

94

Cite Share

Serum CA 125 levels in preoperative evaluation of pelvic masses.

Vasilev SA, Schlaerth JB, Campeau J, Morrow CP.

Obstet Gynecol. 1988 May;71(5):751-6.

PMID: 3162763

Cite Share

The Papanicolaou test and screening for cervical cancer.

Vasilev SA, Scott RS.

JAMA. 1997 Aug 27;278(8):634. doi: 10.1001/jama.278.8.634.

PMID: 9272890 No abstract available.

106

Cite Share

Cytogenetic changes in ovarian mucinous cystadenocarcinoma of low malignant potential with persistent pseudomyxoma peritonei.

Vasilev SA, Meloni AM, Sandberg AA.

Cancer Genet Cytogenet. 1995 Feb;79(2):160-3. doi: 10.1016/0165-4608(94)00141-w.

PMID: 7889512

112

Cite Share

Idiopathic CD4+ T-lymphocytopenia and recurrent vulvar intraepithelial neoplasia.

Park K, Monk BJ, Wilczynski S, Ito JI Jr, Vasilev SA.

Obstet Gynecol. 1994 Oct;84(4 Pt 2):712-4.

PMID: 9205460

121

Cite Share

Follicle regulatory protein: a novel marker for granulosa cell cancer patients.

Rodgers KE, Marks JF, Ellefson DD, Yanagihara DL, Tonetta SA, Vasilev SA, Morrow CP, Montz FJ, diZerega GS.

Gynecol Oncol. 1990 Jun;37(3):381-7. doi: 10.1016/0090-8258(90)90372-r.

PMID: 1693585

Shammas N, Avila R, Khatchadourian C, Spencer-Smith EL, Stern L, et al. Minimally invasive cytoreductive surgery in advanced ovarian cancer: A nonselected consecutive series of robotic-assisted cases. Clin J Obstet Gynecol. 2023; 6: 032-037.

DOI: 10.29328/journal.cjog.1001126

https://www.obstetricgynecoljournal.com/articles/cjog-aid1126.pdf

Amazon Author page with list of BOOKS